Skip to content
10-K/A

Annual Report

Cellectar Biosciences, Inc. CLRB

0001104659-26-053090

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 29, 2026 4.24M sh